drugset / Trial / NCT00772304
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
RandomizedSingle-groupDouble-blindTreatment
Summary
To compare patient perceptions of the sensory attributes, including taste and aftertaste, of Olopatadine relative to azelastine when administered as a single dose in patients with allergic rhinitis.
Timeline
- Start
- 2008-10
- Primary completion
- 2008-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azelastine | Small molecule | 137 ug | Intranasal |
| Subject | Olopatadine | Other / unclassified | 0.6 % | Intranasal |